PMDA — authorised 23 March 2021
- Marketing authorisation holder: Bayer Yakuhin, Ltd.
- Status: approved
🇯🇵 Vitrakvi in Japan
PMDA authorised Vitrakvi on 23 March 2021
Marketing authorisation
Vitrakvi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Vitrakvi approved in Japan?
Yes. PMDA authorised it on 23 March 2021.
Who is the marketing authorisation holder for Vitrakvi in Japan?
Bayer Yakuhin, Ltd. holds the Japanese marketing authorisation.